(Q46269347)

English

A prospective study of body fat redistribution, lipid, and glucose parameters in HIV-infected patients initiating combination antiretroviral therapy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A prospective study of body fat redistribution, lipid, and glucose parameters in HIV-infected patients initiating combination antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

anti-retroviral agent

0 references

Sharon Walmsley

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Angela M. Cheung

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

George Fantus

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Kevin Gough

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Fiona Smaill

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Azad

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Christina Diong

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Janet Raboud

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

314-323

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18977720%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Decline in deaths from AIDS due to new antiretrovirals

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Stavudine versus zidovudine and the development of lipodystrophy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Antiretroviral therapies associated with lipoatrophy in HIV-infected women

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

A 48-week, randomized, open-label comparison of three abacavir-based substitution approaches in the management of dyslipidemia and peripheral lipoatrophy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Metabolic effects of a growth hormone-releasing factor in patients with HIV.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Efficacy of contact lens systems against recent clinical and tap water Acanthamoeba isolates

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: a substudy from the Antiretroviral Regimen Evaluation Study (ARES).

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strate

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Long-Term Body Fat Outcomes in Antiretroviral-Naive Participants Randomized to Nelfinavir or Efavirenz or Both Plus Dual Nucleosides

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Reproducibility of DXA estimations of body fat in HIV lipodystrophy: implications for clinical research.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1310%2FHCT0905-314

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46269347&oldid=1267462577"